280 related articles for article (PubMed ID: 12941575)
1. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
Di Monte DA
Lancet Neurol; 2003 Sep; 2(9):531-8. PubMed ID: 12941575
[TBL] [Abstract][Full Text] [Related]
2. [Genetics and environmental factors of Parkinson disease].
Broussolle E; Thobois S
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
[TBL] [Abstract][Full Text] [Related]
3. [Molecular biology for familial Parkinson's disease].
Shiba K; Hattori N
Nihon Rinsho; 2004 Sep; 62(9):1617-22. PubMed ID: 15462374
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic approaches to Parkinson's disease pathogenesis.
Betarbet R; Sherer TB; Di Monte DA; Greenamyre JT
Brain Pathol; 2002 Oct; 12(4):499-510. PubMed ID: 12408237
[TBL] [Abstract][Full Text] [Related]
5. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
6. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.
Barzilai A; Melamed E
Trends Mol Med; 2003 Mar; 9(3):126-32. PubMed ID: 12657434
[TBL] [Abstract][Full Text] [Related]
9. [The genetics of Parkinson disease].
Toft M; Aasly J
Tidsskr Nor Laegeforen; 2004 Apr; 124(7):922-4. PubMed ID: 15060636
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration.
Uversky VN
Cell Tissue Res; 2004 Oct; 318(1):225-41. PubMed ID: 15258850
[TBL] [Abstract][Full Text] [Related]
11. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
12. Rotenone neurotoxicity: a new window on environmental causes of Parkinson's disease and related brain amyloidoses.
Trojanowski JQ
Exp Neurol; 2003 Jan; 179(1):6-8. PubMed ID: 12504862
[No Abstract] [Full Text] [Related]
13. Genetics of Parkinson's disease.
Morris HR
Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116
[TBL] [Abstract][Full Text] [Related]
14. New aspects of genetic contributions to Parkinson's disease.
Hofer A; Gasser T
J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease: from causes to mechanisms.
Corti O; Hampe C; Darios F; Ibanez P; Ruberg M; Brice A
C R Biol; 2005 Feb; 328(2):131-42. PubMed ID: 15770999
[TBL] [Abstract][Full Text] [Related]
16. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
[TBL] [Abstract][Full Text] [Related]
17. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in Parkinson's disease.
McInerney-Leo A; Hadley DW; Gwinn-Hardy K; Hardy J
Mov Disord; 2005 Jan; 20(1):1-10. PubMed ID: 15503301
[TBL] [Abstract][Full Text] [Related]
19. Genetic and environmental risk factors in Parkinson's disease.
Veldman BA; Wijn AM; Knoers N; Praamstra P; Horstink MW
Clin Neurol Neurosurg; 1998 Mar; 100(1):15-26. PubMed ID: 9637199
[TBL] [Abstract][Full Text] [Related]
20. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
